| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/17/2008 | US20080015222 New Heterocyclic Amides |
| 01/17/2008 | US20080015221 Compound capable of cytoskeleton and induction of cell elongation and process for synthesizing the same |
| 01/17/2008 | US20080015220 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015214 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 01/17/2008 | US20080015201 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 01/17/2008 | US20080015199 Triazolone derivatives |
| 01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015184 Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015178 Benzimidazoles, process for their preparation and use thereof as medicament |
| 01/17/2008 | US20080014660 High Quantum Yield Acridinium Compounds and Their Uses in Improving Assay Sensitivity |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080012475 Pyrene Based Compound, And Light Emitting Transistor Element And Electroluminescence Element Using The Same |
| 01/17/2008 | DE112005003147T5 Verfahren Method |
| 01/17/2008 | DE102006032824A1 Substituierte Indazole Substituted indazoles |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2658417A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| 01/17/2008 | CA2658097A1 Pentadienamide derivatives |
| 01/17/2008 | CA2657601A1 Substituted indazoles |
| 01/17/2008 | CA2657381A1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhibitors |
| 01/17/2008 | CA2657369A1 Short-acting benzodiazepine salts and their polymorphic forms |
| 01/17/2008 | CA2657347A1 Short-acting benzodiazepine salts and their polymorphic forms |
| 01/17/2008 | CA2657300A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 01/17/2008 | CA2657227A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | CA2657151A1 Isoindoline derivatives for the treatment of arrhythmias |
| 01/17/2008 | CA2657117A1 Crystals of benzoxadiazole derivative |
| 01/17/2008 | CA2657078A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | CA2657069A1 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 01/17/2008 | CA2657062A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/17/2008 | CA2657006A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/17/2008 | CA2655750A1 2-arylindole derivatives as mpges-1 inhibitors |
| 01/17/2008 | CA2653698A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | CA2653697A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/16/2008 | EP1878733A1 Pyrimidine derivatives as ALK-5 inhibitors |
| 01/16/2008 | EP1878732A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 01/16/2008 | EP1878728A2 Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders |
| 01/16/2008 | EP1878726A1 Substituted sulphoximines as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same and uses of the same |
| 01/16/2008 | EP1878725A2 Pyrimidine derivatives and their use as CB2 modulators |
| 01/16/2008 | EP1878721A1 4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 01/16/2008 | EP1877495A2 Reactive azo dyes, methods for the production thereof and their use |
| 01/16/2008 | EP1877404A2 Novel cyclic amines |
| 01/16/2008 | EP1877401A2 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/16/2008 | EP1877400A1 Vanilloid receptor ligands and their use in treatments |
| 01/16/2008 | EP1877399A1 Triazole derivatives as vasopressin antagonists |
| 01/16/2008 | EP1877398A1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 01/16/2008 | EP1877397A1 Quinazoline derivatives as inhibitors of egf and/or erbb2 receptor tyrosine kinase |
| 01/16/2008 | EP1877396A1 4-(pyridin-3-yl)-2-(pyridin-2-yl)-1,2-dihydro-3h-pyrazol-3-one derivatives as specific hif-prolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases |
| 01/16/2008 | EP1877395A2 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]propionic acid ethyl ester |
| 01/16/2008 | EP1877386A1 Herbicidally active phenylsulphonyl-urea |
| 01/16/2008 | EP1877385A1 Pyrimidines and pyrazines useful as modulators of ion channels |
| 01/16/2008 | EP1877383A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 01/16/2008 | EP1877380A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators |
| 01/16/2008 | EP1877379A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 01/16/2008 | EP1877378A2 Oxindole compounds and their uses as therapeutic agents |
| 01/16/2008 | EP1877052A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 01/16/2008 | EP1755593B1 Naphthalene derivatives useful as histamine-3-receptor ligands |
| 01/16/2008 | EP1713778B1 Benzazepine derivatives as histamine h3 antagonists |
| 01/16/2008 | EP1601659B1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1340748B1 Quinazoline derivatives and drugs |
| 01/16/2008 | EP1317432B1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 01/16/2008 | EP1305311B1 Tartrate salt of thiazolidinedione derivative |
| 01/16/2008 | EP1122242B1 Cyanophenyl derivatives |
| 01/16/2008 | EP0620003B1 Vasopressin antagonist and oxytocin antagonist |
| 01/16/2008 | CN101107244A Organic compound, charge transport material and organic electroluminescent element containing the same |
| 01/16/2008 | CN101107243A Substituted triazole derivatives as oxytocin antagonists |
| 01/16/2008 | CN101107242A 阿立哌唑的盐 Aripiprazole salt |
| 01/16/2008 | CN101107241A 氟烷基吡咯烷衍生物 Fluoroalkyl pyrrolidine derivative |
| 01/16/2008 | CN101107233A 1H-imidiazole derivatives as cannabinoid CB2 receptor modulators |
| 01/16/2008 | CN101107231A Imidazole and benzimidazole derivatives useful as histamine H3 antagonists |
| 01/16/2008 | CN101106998A Mitotic kinesin inhibitors |
| 01/16/2008 | CN101104615A Anticancer cytoskeleton inhibiting and cell elongation inducing compound and synthetic method thereof |
| 01/16/2008 | CN101104598A Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives |
| 01/15/2008 | US7319149 Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
| 01/15/2008 | US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
| 01/15/2008 | US7319106 such as (cis)-6-(3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane; for controlling synaptic transmission, neurotransmitter release |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7319098 1,3-dioxoisoindole derivatives having selective antagonism of T-type calcium channel |
| 01/15/2008 | US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride |
| 01/15/2008 | US7319084 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control |
| 01/15/2008 | US7319041 Applications of acridinium compounds and derivatives in homogeneous assays |
| 01/15/2008 | CA2218479C 1,4-di-substituted piperidine derivatives |
| 01/10/2008 | WO2008006040A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006032A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008005910A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 01/10/2008 | WO2008005576A1 Modulators of metabolism and the treatment of disorders related thereto |
| 01/10/2008 | WO2008005338A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2008005268A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 01/10/2008 | WO2008004946A1 New pyridine analogues |
| 01/10/2008 | WO2008004945A1 Novel crystalline forms i and ii |
| 01/10/2008 | WO2008004944A1 Novel crystalline form ii |
| 01/10/2008 | WO2008004942A1 New pyridine analogues |
| 01/10/2008 | WO2008004941A1 New pyridine analogues |
| 01/10/2008 | WO2008004716A1 Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |